Colorectal cancer screening with faecal occult blood testing: Community intention, knowledge, beliefs and behaviour

S Tong, K Hughes, Brian Oldenburg, Chris B Del Mar

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

Abstract

Colorectal cancer (CRC) is the fourth most frequent malignancy in both sexes worldwide and the second most frequent in industrialised countries. In Australia, the United Kingdom and the United States, the age-standardised incidence of CRC is 31-47 per 100,000 in men and 22-33 per 100,000 in women. Approximately 50% of patients affected will die from this disease 1-3. Early detection is critical in preventing CRC deaths as treatment success is reliant upon the disease being diagnosed at a localised stage. Randomised controlled trials showed that screening by the faecal occult blood test (FOBT) can reduce the death rate from this disease by 15-33 percent. Cost effectiveness analysis indicated that screening for CRC is comparable in cost to breast cancer screening.
Original languageEnglish
Pages (from-to)16-23
Number of pages7
JournalAsia-Pacific Journal of Public Health
Volume18
Issue number1
DOIs
Publication statusPublished - 2006
Externally publishedYes

Fingerprint

Occult Blood
Early Detection of Cancer
Colorectal Neoplasms
Hematologic Tests
Developed Countries
Cost-Benefit Analysis
Randomized Controlled Trials
Breast Neoplasms
Costs and Cost Analysis
Mortality
Incidence
Neoplasms
Therapeutics

Cite this

@article{ec59fea24e6948268480dd1861620138,
title = "Colorectal cancer screening with faecal occult blood testing:: Community intention, knowledge, beliefs and behaviour",
abstract = "Colorectal cancer (CRC) is the fourth most frequent malignancy in both sexes worldwide and the second most frequent in industrialised countries. In Australia, the United Kingdom and the United States, the age-standardised incidence of CRC is 31-47 per 100,000 in men and 22-33 per 100,000 in women. Approximately 50{\%} of patients affected will die from this disease 1-3. Early detection is critical in preventing CRC deaths as treatment success is reliant upon the disease being diagnosed at a localised stage. Randomised controlled trials showed that screening by the faecal occult blood test (FOBT) can reduce the death rate from this disease by 15-33 percent. Cost effectiveness analysis indicated that screening for CRC is comparable in cost to breast cancer screening.",
author = "S Tong and K Hughes and Brian Oldenburg and {Del Mar}, {Chris B}",
year = "2006",
doi = "10.1177/10105395060180010401",
language = "English",
volume = "18",
pages = "16--23",
journal = "Asia-Pacific Journal of Public Health",
issn = "1010-5395",
publisher = "SAGE Publications Ltd",
number = "1",

}

Colorectal cancer screening with faecal occult blood testing: Community intention, knowledge, beliefs and behaviour. / Tong, S; Hughes, K; Oldenburg, Brian; Del Mar, Chris B.

In: Asia-Pacific Journal of Public Health, Vol. 18, No. 1, 2006, p. 16-23.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Colorectal cancer screening with faecal occult blood testing:

T2 - Community intention, knowledge, beliefs and behaviour

AU - Tong, S

AU - Hughes, K

AU - Oldenburg, Brian

AU - Del Mar, Chris B

PY - 2006

Y1 - 2006

N2 - Colorectal cancer (CRC) is the fourth most frequent malignancy in both sexes worldwide and the second most frequent in industrialised countries. In Australia, the United Kingdom and the United States, the age-standardised incidence of CRC is 31-47 per 100,000 in men and 22-33 per 100,000 in women. Approximately 50% of patients affected will die from this disease 1-3. Early detection is critical in preventing CRC deaths as treatment success is reliant upon the disease being diagnosed at a localised stage. Randomised controlled trials showed that screening by the faecal occult blood test (FOBT) can reduce the death rate from this disease by 15-33 percent. Cost effectiveness analysis indicated that screening for CRC is comparable in cost to breast cancer screening.

AB - Colorectal cancer (CRC) is the fourth most frequent malignancy in both sexes worldwide and the second most frequent in industrialised countries. In Australia, the United Kingdom and the United States, the age-standardised incidence of CRC is 31-47 per 100,000 in men and 22-33 per 100,000 in women. Approximately 50% of patients affected will die from this disease 1-3. Early detection is critical in preventing CRC deaths as treatment success is reliant upon the disease being diagnosed at a localised stage. Randomised controlled trials showed that screening by the faecal occult blood test (FOBT) can reduce the death rate from this disease by 15-33 percent. Cost effectiveness analysis indicated that screening for CRC is comparable in cost to breast cancer screening.

U2 - 10.1177/10105395060180010401

DO - 10.1177/10105395060180010401

M3 - Article

VL - 18

SP - 16

EP - 23

JO - Asia-Pacific Journal of Public Health

JF - Asia-Pacific Journal of Public Health

SN - 1010-5395

IS - 1

ER -